Medical Devices Startups
5,183 companies tagged Medical Devices, with their investors and founders.
cellvie develops Therapeutic Mitochondria Transplantation, a technique that augments or replaces failing mitochondria to restore cellular energy metabolism, with initial applications in ischemia-reperfusion injury (starting with kidney transplantation) and in mitochondria-enabled gene therapy for the genetic skin disease Epidermolysis Bullosa. Its therapies target intractable human conditions including organ transplant injury, degenerative aging processes, and rare genetic diseases.
2 investors
Celsus is an AI platform for analyzing medical images, detecting pathologies in mammography, fluorography, and CT scans of the chest and brain. Its diagnostic tools are used in radiology departments to support clinical practice and improve cancer detection.
2 investors
Centaur.ai uses performance-based AI and collective intelligence methods to improve medical decision-making in skin lesion assessment for cancer detection. The company combines expert human judgment with AI algorithms weighted by demonstrated accuracy rather than credentials.
2 investors
Centerline Biomedical develops IOPSยฎ, a 510(k)-cleared endovascular navigation technology that provides real-time 3D image guidance for physicians performing catheterization and other endovascular procedures. The technology is designed to reduce radiation exposure and improve procedural accuracy for interventional cardiologists, vascular surgeons, and other interventionalists.
2 investors
CenTrak provides Real-Time Location System (RTLS) technology for healthcare facilities, including IoT wearables, infrastructure devices, software, and integrations with systems like EMR, CMMS, and Nurse Call. Its solutions cover asset tracking, patient and staff safety, workflow, environmental monitoring, and patient experience across hospitals and health systems.
2 investors
Cepheid develops molecular diagnostic tests and the GeneXpert System, a scalable platform used by healthcare professionals across settings from core labs to near-patient testing. It also runs a Global Access Program to expand access to diagnostic testing for global public health.
2 investors
CeramTec manufactures advanced ceramics and high-performance materials, producing custom-engineered components such as orthopedic and dental implants, hip prostheses, and precision parts for the automotive, electronics, and semiconductor industries. It serves customers in the medical technology and industrial markets worldwide.
2 investors
Avalo is a clinical-stage biotechnology company developing therapeutics targeting the IL-1ฮฒ pathway for immune-mediated inflammatory diseases. Its pipeline includes abdakibart (AVTX-009), tested in a Phase 2 trial for hidradenitis suppurativa, and AVTX-010, a long-acting next-generation anti-IL-1ฮฒ antibody.
2 investors
Ceregate develops a hardware-agnostic computer-brain interface platform designed to restore and reimagine human sensory function through therapeutic applications.
2 investors
CertHub provides software for medical device manufacturers to streamline compliance documentation and regulatory submissions under MDR, IVDR, and other EU regulations. The platform serves small and medium-sized enterprises developing traditional medical devices, in-vitro diagnostics, and software as medical devices.
2 investors
Chipiron develops a low-field MRI system using a patented cryogenic ultrasensitive detection system and AI-based noise cancellation and image reconstruction, aiming to acquire MRI signals in open environments without a Faraday cage. Its technology includes a breast-dedicated imaging sequence designed for clinically relevant scan times.
2 investors
Cimon Medical develops and manufactures Doppler ultrasound technology for healthcare facilities, including the NeoDoppler system for continuous, noninvasive monitoring of cerebral blood flow. Its technology targets the assessment of brain perfusion in newborns, including during incubator transport.
2 investors
CiRC Biosciences develops cellular reprogramming therapies that convert fibroblasts directly into specific neurons and cell types lost in degenerative eye and brain diseases. Its programs target dopaminergic neurons in Parkinson's disease, GABAergic interneurons in refractory epilepsy, and orexin neurons in treatment-resistant narcolepsy, building on prior retinal cell replacement work.
2 investors
Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests. The company serves researchers, clinicians, and biopharma partners with diagnostic tools for conditions like Alzheimer's and Parkinson's.
2 investors
Cirtec provides outsourced design, development, and contract manufacturing services for medical devices, including complex Class III devices. It serves medical device companies as a development and manufacturing partner, operating in the medtech contract manufacturing sector.
2 investors
Cision Vision develops the InVision Shortwave Infrared (SWIR) imaging system and AI-powered tools for pathology and surgery, including real-time intraoperative critical structure identification and lymph node grossing assistance. Its devices target clinical labs and surgical teams, though they are not yet FDA-approved and remain in development.
2 investors
Clarius makes handheld, wireless ultrasound scanners that connect to a smartphone, along with AI-assisted imaging tools (T-Mode and Clarius Intelligence) that label anatomy and guide scanning. The point-of-care ultrasound systems are aimed at clinicians, including novice users, for portable medical imaging.
2 investors
Clear Gene develops RNA diagnostics for detecting residual solid tumors in cancer patients and provides software and reagent kits to help clinical laboratories process COVID-19 samples more efficiently using existing equipment.
2 investors
Clee Medical develops a real-time intraoperative brain imaging platform called Neuro to support neurosurgical procedures. Its tools are aimed at improving precision and efficiency for neurosurgeons performing brain surgery.
2 investors
Cleerly is an AI-enabled software platform that analyzes coronary artery disease through advanced imaging analysis, providing clinically actionable insights to support heart attack prevention and personalized patient care.
2 investors
Cleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.
2 investors
Cloud DX develops the Connected Health platform, including remote patient monitoring software, mobile apps, and devices such as VITALITI for capturing vital signs. The company serves healthcare providers and patients, operating in the digital health and remote monitoring category.
2 investors
Coagulant Therapeutics is a biopharmaceutical company, formed in 2019, developing biologics with a focus on hematology and coagulation-related therapeutics.
2 investors
CognifiSense develops Virtual Reality Neuropsychological Therapy (VRNT), an immersive VR program that retrains the brain's pain pathways to reduce chronic pain without medication or invasive treatments. It serves patients experiencing chronic pain and the healthcare providers who treat them.
2 investors